Office of Technology Commercialization

Ramachandran, P V

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Selective Therapeutic for C. diff Infection
2018-RAMA-68247
  1. Pharmaceuticals
Ramachandran, P V
Preparation of Carboxamides from Carboxylic Acids using Amine-Boranes
2020-RAMA-68861
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Ramachandran, P V
Simple and Economical Preparation of Aminoboranes for Use in Organic Synthesis
2020-RAMA-68862
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Ramachandran, P V
New Drug Candidate for Methicillin-Resistant Staphylococcus Aureus Bacterial Infection and Other Drug Resistant Bacteria
2020-RAMA-68859
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Ramachandran, P V
Anti-bacterial Compounds to Treat Neisseria gonorrhoeae Infections
2020-RAMA-68860
  1. Pharmaceuticals
Ramachandran, P V
Open-Flask Hydroboration of Alkenes Using Ammonia Borane
2017-RAMA-67641
  1. Chemistry and Chemical Analysis
Ramachandran, P V
Amine-Boranes Bearing Borane-Intolerant Functionalities
2017-RAMA-67642
  1. Chemistry and Chemical Analysis
Ramachandran, P V
Preparation of Amine Boranes, Ammonia Borane, and Phosphine Boranes
2014-RAMA-66892
  1. Chemistry and Chemical Analysis
Ramachandran, P V
Improved Process for Preparing Ammonia Borane
65602
  1. Chemistry and Chemical Analysis
Ramachandran, P V

Details

Dr. P. Veeraraghavan Ramachandran is a Professor of Chemistry at Purdue University. He received his B.S. and M.S. from Calicut University, Ph.D. from the Indian Institute of Technology, and postdoctoral fellowship at Purdue. Dr. Ramachandran was awarded the Vikram Sarabhai Chair of the Indian National Science Academy (recognizes distinguished senior scientists) for 2014-2015 and was selected as a Fellow of the American Chemical Society in 2012. Dr. Ramachandran's research focuses on the application of organoborane and fluoroorganic chemistry. His lab develops novel methods and reagents to facilitate the synthesis of a variety of complex molecular targets, particularly for the treatment of cancer, inflammation, and central nervous system disorders. They also focus on the mechanistic aspects of such methodologies.

For additional information visit Dr. Ramachandran's Purdue https://www.chem.purdue.edu/people/directory/faculty/details/55
or his research group, PVR Group, website: http://www.chem.purdue.edu/chandran/